In pancreatic cancer, PEDF was found to serve as an anti-inflammatory immunomodulator that inhibits macrophage activation and migration45, whereas in prostate cancer it was found to induce migration of M1-type differentiated macrophages46,47. This evidence concerns the gene SERPINF1 and prostate carcinoma.